Heterogeneity of T-cell beta-chain gene rearrangements in human leukaemias and lymphomas. 1985

T H Rabbitts, and A Stinson, and A Forster, and L Foroni, and L Luzzatto, and D Catovsky, and L Hammarström, and C I Smith, and D Jones, and A Karpas

The state of T-cell receptor beta-chain gene rearrangement in human T-cell leukaemias has been analysed. All forms of leukaemia tested (T-CLL, ALL, PLL, Sezary syndrome and ATL) exhibit rearrangements of C beta genes confirming the clonality of these neoplasias. However we find no evidence for common gene rearrangements nor for restricted rearrangement patterns within this type of neoplasia. We find evidence of T-cells with C beta 1 and C beta 2 rearrangements, sometimes associated with Igh JH rearrangements, but several cases of T-cell leukaemia with a marker inversion of chromosome 14 (q11;q32) do not have Igh JH rearrangements. The results suggest that TCR beta gene rearrangement occurs early in T-cell ontogeny but that this rearrangement is most often irrelevant to leukaemogenesis.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004262 DNA Restriction Enzymes Enzymes that are part of the restriction-modification systems. They catalyze the endonucleolytic cleavage of DNA sequences which lack the species-specific methylation pattern in the host cell's DNA. Cleavage yields random or specific double-stranded fragments with terminal 5'-phosphates. The function of restriction enzymes is to destroy any foreign DNA that invades the host cell. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. They are also used as tools for the systematic dissection and mapping of chromosomes, in the determination of base sequences of DNAs, and have made it possible to splice and recombine genes from one organism into the genome of another. EC 3.21.1. Restriction Endonucleases,DNA Restriction Enzyme,Restriction Endonuclease,Endonuclease, Restriction,Endonucleases, Restriction,Enzymes, DNA Restriction,Restriction Enzyme, DNA,Restriction Enzymes, DNA
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA

Related Publications

T H Rabbitts, and A Stinson, and A Forster, and L Foroni, and L Luzzatto, and D Catovsky, and L Hammarström, and C I Smith, and D Jones, and A Karpas
December 1986, Molecular immunology,
T H Rabbitts, and A Stinson, and A Forster, and L Foroni, and L Luzzatto, and D Catovsky, and L Hammarström, and C I Smith, and D Jones, and A Karpas
July 1985, Lancet (London, England),
T H Rabbitts, and A Stinson, and A Forster, and L Foroni, and L Luzzatto, and D Catovsky, and L Hammarström, and C I Smith, and D Jones, and A Karpas
November 1993, Archives of dermatology,
T H Rabbitts, and A Stinson, and A Forster, and L Foroni, and L Luzzatto, and D Catovsky, and L Hammarström, and C I Smith, and D Jones, and A Karpas
April 1990, International journal of cancer,
T H Rabbitts, and A Stinson, and A Forster, and L Foroni, and L Luzzatto, and D Catovsky, and L Hammarström, and C I Smith, and D Jones, and A Karpas
August 1985, The New England journal of medicine,
T H Rabbitts, and A Stinson, and A Forster, and L Foroni, and L Luzzatto, and D Catovsky, and L Hammarström, and C I Smith, and D Jones, and A Karpas
September 1986, Journal of immunology (Baltimore, Md. : 1950),
T H Rabbitts, and A Stinson, and A Forster, and L Foroni, and L Luzzatto, and D Catovsky, and L Hammarström, and C I Smith, and D Jones, and A Karpas
February 1994, European journal of clinical investigation,
T H Rabbitts, and A Stinson, and A Forster, and L Foroni, and L Luzzatto, and D Catovsky, and L Hammarström, and C I Smith, and D Jones, and A Karpas
November 1986, Japanese journal of cancer research : Gann,
T H Rabbitts, and A Stinson, and A Forster, and L Foroni, and L Luzzatto, and D Catovsky, and L Hammarström, and C I Smith, and D Jones, and A Karpas
June 1986, Human pathology,
T H Rabbitts, and A Stinson, and A Forster, and L Foroni, and L Luzzatto, and D Catovsky, and L Hammarström, and C I Smith, and D Jones, and A Karpas
March 1991, Cancer research,
Copied contents to your clipboard!